IMM Immupharma Plc

TIDMIMM

Immupharma PLC

15 February 2018

 
   15 February 2018 
 
 

ImmuPharma PLC

("ImmuPharma" or the "Company")

London Investor Evening

Monday 26 February 2018 @ 6pm

ImmuPharma PLC (LSE: IMM), specialist drug discovery and development company, is pleased to announce that Tim McCarthy, Chairman, will be presenting at an investor evening hosted by Turner Pope Investments (TPI) Ltd. TPI acted as agent in the recent GBP10 million fundraise by ImmuPharma.

The event will be held on Monday 26(th) February 2018 in London, EC2 and will commence at 6pm. Further details on the event will be provided upon registration. To Register your interest, please email lisa.baderoon@immupharma.com and info@turnerpope.com or call 0203 621 4120.

-Ends-

 
 For further information please 
  contact: 
                                           + 44 (0) 20 
   ImmuPharma plc (www.immupharma.org)       7152 4080 
   Tim McCarthy, Chairman 
   Lisa Baderoon, Head of Investor 
    Relations 
    lisa.baderoon@immupharma.com          + 44 (0) 7721 
    Twitter: @immupharma                      413496 
   Northland Capital Partners Limited 
    (NOMAD & Broker) 
    David Hignell, Jamie Spotswood, 
    Corporate Finance                     +44 (0)20 3861 
    Rob Rees, Corporate Broking                6625 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRAMMGMZKDLGRZM

(END) Dow Jones Newswires

February 15, 2018 02:01 ET (07:01 GMT)

Immupharma (LSE:IMM)
Historical Stock Chart
From Mar 2024 to Apr 2024

Immupharma (LSE:IMM)
Historical Stock Chart
From Apr 2023 to Apr 2024